New research reveals that contrary to conventional belief, primary glomerular diseases are not necessarily benign for ...

New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children ...

New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

"Eledon takes transplant rejection therapy to Phase III on mixed results" was originally created and published by Clinical ...

An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney ...

Eledon shares drop as tegoprubart misses the main goal in Phase 2 kidney transplant trial, though safety signals and kidney ...

Nephrologists must capitalize on new therapeutic agents and opportunities to carry on the momentum of the field, according to ...

In FSGS, podocytes are damaged, like a net with torn holes, allowing protein to leak into the urine, creating a harmful ...

The benefits are observed across patient subtypes and potentially offer the chance to avoid dialysis and implement a new standard of care.

The growing burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) has been a major driver of demand for ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly reduce the risk of kidney ...